08Aug 2021
International multicentre observational study to assess the efficacy and safety of a 0.5 mg/kg/day starting dose of oral corticosteroids to treat bullous pemphigoid

International multicentre observational study to assess the efficacy and safety of a 0.5 mg/kg/day starting dose of oral corticosteroids to treat bullous pemphigoid

European guidelines propose a 0.5 mg/kg/day dose of oral prednisone as initial treatment of bullous pemphigoid (BP). We assessed the safety and efficacy of this regimen depending on BP extent, and patients’general condition. In a prospective international study, we consecutively included all patients diagnosed with BP. Patients received a 0.5 mg/kg/day dose of prednisone, then gradually tapered 15 days after disease control, with the aim of stopping prednisone or maintaining minimal treatment (0.1 mg/kg/day) within 6 months after the start of treatment...

  • #dermatology

Like

Save

Share